|
A supplier's claim of compliance doesn't make it so. HHS's new peptide policy requires testing and documentation well beyond a typical certificate of analysis. In a guest Compounding Interests column on LinkedIn this week, APC board member Matt Johnson explains why he has yet to see a COA satisfying every applicable requirement — and why pharmacies should carefully verify suppliers' compliance claims before purchasing peptide API. |